| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 04/30/2009 | US20090111838 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors |
| 04/30/2009 | US20090111819 New pyridazin-3(2h)-one derivatives |
| 04/30/2009 | US20090110662 Modification of biological targeting groups for the treatment of cancer |
| 04/30/2009 | CA2704040A1 Synthesis of quaternary salt compounds |
| 04/30/2009 | CA2703717A1 Synthesis of quaternary salt compounds |
| 04/30/2009 | CA2703479A1 Therapeutic substituted lactams |
| 04/30/2009 | CA2702786A1 Novel imidazole derivatives |
| 04/30/2009 | CA2701747A1 Novel imidazole derivatives |
| 04/30/2009 | CA2701275A1 Novel kinase inhibitors |
| 04/29/2009 | EP2053046A1 Novel imidazole derivatives |
| 04/29/2009 | EP2053045A1 Novel imidazole derivatives |
| 04/29/2009 | EP2053044A1 Novel imidazole derivatives |
| 04/29/2009 | EP2053041A2 1,3,5-Trisubstituted 2(1H)-pyridones as AMPA receptor inhibitors useful for the treatment of eg Parkinson's disease |
| 04/29/2009 | EP2051974A1 Tetrahydrobenzothiophene derivatives |
| 04/29/2009 | EP1828127A4 INSECTICIDAL BIS(SUBSTITUTED PHENYL)-1-äÝ4-(SATURATED HETEROCYCLYL-SUBSTITUTED)PHENYLMETHYL¨-(4-PIPERIDYL)üMETHANE DERIVATIVES |
| 04/29/2009 | EP1450806B1 Use of sulfonamide derivatives in the treatment of obesity or for the reduction of food intake |
| 04/29/2009 | EP1446379B1 Aryl aniline beta-2 adrenergic receptor agonists |
| 04/29/2009 | EP1438288B1 Substituted thioacetamides |
| 04/29/2009 | CN101421258A Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 04/29/2009 | CN101421252A 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin D2 receptor antagonists |
| 04/29/2009 | CN101421250A 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them |
| 04/29/2009 | CN101421234A Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor |
| 04/29/2009 | CN100482229C Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 04/28/2009 | US7524959 Biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenyl-carbamoyl)ethyl]piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, asthma |
| 04/28/2009 | US7524957 Compounds effecting glucokinase |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524869 Taxanes having a C10 ester substituent |
| 04/28/2009 | US7524864 Methods of treating sleep disorders |
| 04/28/2009 | US7524863 Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
| 04/28/2009 | US7524861 Process for the preparation of a hydrate of an anthranilic acid derivative |
| 04/28/2009 | US7524859 Treating hyperproliferative disorders such as gastrointestinal cancer, breast cancer, head cancer, or neck cancer; N-(4-trifluoromethoxyphenyl) 3-[(quinolin-4-ylmethyl)amino]thiophene-2-carboxamide |
| 04/28/2009 | US7524849 5-arylpyrimidines as anticancer agents |
| 04/28/2009 | US7524848 Diaza heterocyclic amide compounds and their uses |
| 04/28/2009 | US7524846 heterocylcyclic amines used for treating or preventing conditions ameliorated by monoamine reuptake such as vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 04/28/2009 | US7524843 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
| 04/28/2009 | US7524839 Such as 1-phenylsulfonyl-4-piperazinylindole hydrochloride for treatment or prophylaxis of disease mediated by serotonin related receptor, obesity, and/or central nervous system disorder |
| 04/28/2009 | US7524838 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them |
| 04/28/2009 | US7524837 Benzotriazapinone salts and methods for using same |
| 04/28/2009 | CA2273328C 5-cyclo indole compounds as 5-ht1d receptor ligands |
| 04/28/2009 | CA2227762C Substituted aminouracils |
| 04/23/2009 | WO2009052237A1 Inhibitors of c-fms kinase |
| 04/23/2009 | WO2009052068A1 Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof |
| 04/23/2009 | WO2009052065A1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 04/23/2009 | WO2009051660A2 Compounds for activating tgf-beta signaling |
| 04/23/2009 | WO2009051112A1 Amide compounds and use of the same |
| 04/23/2009 | WO2009050999A1 Indolium compound and optical recording material using the compound |
| 04/23/2009 | WO2009050235A1 Cgrp antagonists |
| 04/23/2009 | WO2009050220A1 Indazoles as glucocorticoid receptor ligands |
| 04/23/2009 | WO2009024342A3 Novel microbiocides |
| 04/23/2009 | WO2009017719A3 Modulators of ccr9 receptor and methods of use thereof |
| 04/23/2009 | WO2009013915A8 Inhibitor of plasminogen activator inhibitor-1 |
| 04/23/2009 | WO2009004383A3 Aza-bicyclohexane compounds useful as anticoagulants |
| 04/23/2009 | WO2009004171A3 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof |
| 04/23/2009 | WO2009001060A3 Use of compounds for preparing anti-tuberculosis agents |
| 04/23/2009 | WO2008152014A3 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases |
| 04/23/2009 | WO2008133896A3 Dual-acting antihypertensive agents |
| 04/23/2009 | US20090105291 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 04/23/2009 | US20090105286 Low-molecular inhibitors of cytohesin-family guanine nucleotide exchange factors |
| 04/23/2009 | US20090105280 Novel Aromatic Nitro Compounds |
| 04/23/2009 | US20090105279 Tetrahydrofuro[2,3-b]furyl carbamates containing an (oxy)hydrazide group; these compounds target the HIV protease in both wild type and mutant strains of HIV. |
| 04/23/2009 | US20090105271 Pyridyl sulfonamides as modulators of ion channels |
| 04/23/2009 | US20090105264 Substituted Nicotinamide Compounds |
| 04/23/2009 | US20090105251 Renin inhibitors |
| 04/23/2009 | US20090105241 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| 04/23/2009 | US20090105231 Amide derivatives as rock inhibitors |
| 04/23/2009 | US20090105226 administering 7-Benzyloxy-3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine, for the treatment of Alzheimer's disease, cognitive impairment, dementia, epilepsy, neuropathic pain, Parkinson's disease, schizophrenia, attention deficit disorder or depression in humans |
| 04/23/2009 | US20090105224 Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor |
| 04/23/2009 | US20090105215 Heterocyclic compounds, methods for the preparation thereof, and uses thereof |
| 04/23/2009 | US20090104265 Polymorphs of N-(4-chloro-3-methyl-5-isoxazolyl) 2-[2-methyl-4,5-(methylenedioxy)phenylacetyl] thiophene-3-sulfonamide, sodium salt |
| 04/23/2009 | US20090101890 Azaperylenes as organic semiconductors |
| 04/23/2009 | CA2702898A1 Inhibitors of c-fms kinase |
| 04/22/2009 | EP2050739A1 Quinazoline derivative |
| 04/22/2009 | EP2049528A2 Fungicide n-cycloalkyl-carboxamide derivatives |
| 04/22/2009 | EP2049521A2 Novel pyridazine derivatives |
| 04/22/2009 | EP2049502A1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 04/22/2009 | EP2049501A1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 04/22/2009 | EP2049500A1 Cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 04/22/2009 | EP2049495A2 N-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives as prostaglandine receptor inhibitors |
| 04/22/2009 | EP2049486A2 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 04/22/2009 | EP2049107A2 Substituted imidazolone derivatives, preparation and uses |
| 04/22/2009 | EP1802572B1 Indol derivatives as inhibitors of soluble adenylyl cyclase |
| 04/22/2009 | EP1718632B1 Pyrimidine derivatives as orexin receptor antagonists |
| 04/22/2009 | EP1673354B1 Arylindenopyridines and arylindenopyrimidines and their use as adenosine a2a receptor antagonists |
| 04/22/2009 | EP1592389B1 Piperazine-2-carboxamide derivatives |
| 04/22/2009 | EP1549628B1 Method of preparing amino acid taxane derivatives and polymer conjugates containing the same |
| 04/22/2009 | EP1381366B1 Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 04/22/2009 | CN101415698A Fungicide n-cyclopropyl-sulfonylamide derivatives |
| 04/22/2009 | CN101415687A Binding inhibitor of sphingosine-1-phosphate |
| 04/22/2009 | CN101415674A Pyrrolidine derivatives as ERK inhibitors |
| 04/22/2009 | CN100481571C Luminescent element material and luminescent element comprising the same |
| 04/22/2009 | CN100480248C Malonamide derivatives as gamma-secretase inhibitors |
| 04/22/2009 | CN100480242C CDK-inhibitory pyrimidines, and production and use thereof as pharmaceutical agents |
| 04/21/2009 | US7521561 Biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenyl-carbamoyl)ethyl]piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, asthma |
| 04/21/2009 | US7521464 drugs have beta-amyloid peptide production inhibitory activity, such as 2-(2-benzo[b]thiophen-4-yl-acetylamino)-N-(5-phenyl-2H-pyrazol-3-yl)-propionamide, useful for treatment of Alzheimer's disease and Down's Syndrome |
| 04/21/2009 | US7521462 4-Amino-piperidine derivatives as monoamine uptake inhibitors |
| 04/21/2009 | US7521453 e.g. 5-Bromo-2-(3-methylisoxazol-5-ylmethylamino)-4-(5-cyclopropyl- 1H-pyrazol-3-ylamino)pyrimidine; anticarcinogenic, antitumor agents; breast, prostate, colon cancer |
| 04/21/2009 | US7521448 N-substituted benzimidazolyl c-Kit inhibitors |
| 04/21/2009 | US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 04/21/2009 | US7521062 Thiosemicarbazones as anti-virals and immunopotentiators |
| 04/21/2009 | US7521004 Chromene compound |